MK-6096

DRUG4 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Diabetic Neuropathy, PainfulHeadacheMigrainePolysomnographyPrimary Insomnia

Phase 1

A Study to Evaluate the Effects of Single Doses of MK-1064 and MK-6096 on Polysomnography (PSG) (MK-1064-003)

CompletedNCT02549027

Merck Sharp & Dohme LLCPolysomnography

Start: 2009-11-06End: 2010-04-06Updated: 2018-10-23

Phase 2

Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011)

CompletedNCT01021852

Merck Sharp & Dohme LLCPrimary Insomnia

Start: 2009-11-30End: 2011-02-01Updated: 2018-11-06

A Study of the Safety and Efficacy of MK-6096 for Migraine Prophylaxis in Participants With Episodic Migraine (MK-6096-020)

CompletedNCT01513291

Merck Sharp & Dohme LLCHeadache, Migraine

Start: 2012-02-06End: 2012-10-03Updated: 2018-11-07

Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)

CompletedNCT01564459

Merck Sharp & Dohme LLCDiabetic Neuropathy, Painful

Start: 2012-03-26End: 2013-04-18Updated: 2018-11-07